Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland
Initial or interim treatment of those superficial fungal infections of the skin which are accompanied by highly inflammatory or eczematous skin conditions, e.g. in the region of the hands, the interdigital spaces of the feet and in the inguinal and genital regions.
Cutaneous use.
Travocort should be applied twice daily to the diseased areas of skin.
Treatment with Travocort must be terminated after regression of the inflammatory or eczematous skin conditions or at the latest after 2 weeks and therapy continued or followed up with a glucocorticoid-free anti-fungal preparation. This applies in particular for use in the inguinal and genital regions.
Dose adjustments are not required when Travocort is administered to children aged 2 years or older and adolescents.
Only limited data on the safety of Travocort in children aged below 2 years are available, for more details see section 5.1.
Results from acute toxicity studies do not indicate that any risk of acute intoxication is to be expected following a single dermal application of an overdose (application over a large area under conditions favourable to absorption) or inadvertent oral ingestion.
3 years.
Do not store above 30ºC.
Tube with 15 g made of pure aluminium, interior wall coated with epoxy resin, and with a polyester-based external coating, fold seal ring is made of polyamide based heat sealable material. The screw cap is made of high density polyethylene.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
